Top U.S. cholesterol-lowering drugs based on revenue 2013
This statistic depicts the top ten HMG-CoA reductase inhibitors based on total U.S. revenue in 2013. In that year, Livalo was among the leading HMG-CoA reductase inhibitors generating a revenue of 124 million U.S. dollars in the United States. HMG-CoA reductase inhibitors or statins help lower cholesterol levels and is central in cholesterol production within the liver. It is used to prevent heart disease and decrease mortality within those with pre-existing cardiovascular disease.
